Invention Grant
US08969413B2 Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid
有权
使用（1S，3S）-3-氨基-4-二氟甲基-1-戊酸的方法
- Patent Title: Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid
- Patent Title (中): 使用（1S，3S）-3-氨基-4-二氟甲基-1-戊酸的方法
-
Application No.: US13581187Application Date: 2011-02-25
-
Publication No.: US08969413B2Publication Date: 2015-03-03
- Inventor: Richard B. Silverman , Stephen L. Dewey , Steven Miller
- Applicant: Richard B. Silverman , Stephen L. Dewey , Steven Miller
- Applicant Address: US FL Coral Gables US NY Upton US IL Evanston
- Assignee: Catalyst Pharmaceutical Partners,Brookhaven Science Associates,Northwestern University
- Current Assignee: Catalyst Pharmaceutical Partners,Brookhaven Science Associates,Northwestern University
- Current Assignee Address: US FL Coral Gables US NY Upton US IL Evanston
- Agency: Keller Life Science Law, P.A.
- Agent Michael J. Keller
- International Application: PCT/US2011/026309 WO 20110225
- International Announcement: WO2011/106692 WO 20110901
- Main IPC: A01N37/30
- IPC: A01N37/30 ; A61K31/205 ; A61K31/195 ; A61K31/197
Abstract:
(1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid also known as CPP-115 or its pharmaceutically acceptable salts can be used to treat addiction and neurological disorders such as epilepsy without side effects such as visual field defects caused by vigabatrin (Sabril).
Public/Granted literature
- US20130041028A1 METHODS OF USING (1S,3S)-3-AMINO-4-DIFLUOROMETHYLENYL-1-CYCLOPENTANOIC ACID Public/Granted day:2013-02-14
Information query
IPC分类:
